Arcadia Biosciences Inc

NASDAQ RKDA

Download Data

Arcadia Biosciences Inc Stock-Based Compensation for the quarter ending March 31, 2024: USD 138.00 K

Arcadia Biosciences Inc Stock-Based Compensation is USD 138.00 K for the quarter ending March 31, 2024, a -34.91% change year over year. Stock-Based Compensation represents the cost of employee compensation provided in the form of equity-based instruments, such as stock options or restricted stock units.
  • Arcadia Biosciences Inc Stock-Based Compensation for the quarter ending March 31, 2023 was USD 212.00 K, a -18.46% change year over year.
  • Arcadia Biosciences Inc Stock-Based Compensation for the quarter ending March 31, 2022 was USD 260.00 K, a -20.00% change year over year.
  • Arcadia Biosciences Inc Stock-Based Compensation for the quarter ending March 31, 2021 was USD 325.00 K, a -57.90% change year over year.
  • Arcadia Biosciences Inc Stock-Based Compensation for the quarter ending March 31, 2020 was USD 772.00 K, a 39.86% change year over year.
NASDAQ: RKDA

Arcadia Biosciences Inc

CEO Ms. Pamela Haley
IPO Date May 15, 2015
Location United States
Headquarters 202 Cousteau Place, Davis, CA, United States, 95618
Employees 21
Sector Consumer Defensive
Industry Packaged foods
Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Similar companies

SENEA

Seneca Foods Corp A

NA

NA

BRID

Bridgford Foods Corporation

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email